About Rubix LS
Rubix LS is a digital health research and development company focusing on the growing disparity of minority health outcomes. By designing real-world evidence studies within the infectious and rare disease areas, the company is targeting mobile and digital clinical trial options for increasing engagement for minority and underrepresented populations to address wide health outcomes.
Rubix LS's Product Videos
Compete with Rubix LS?
Ensure that your company and products are accurately represented on our platform.
Rubix LS's Products & Differentiators
A fully integrative patient clinical research environment that uses active AI to personalize a cradle to grave data profile that will provide insights to sponsors, payers, providers, and patients a precision therapeutic journey
Expert Collections containing Rubix LS
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Rubix LS is included in 5 Expert Collections, including Clinical Trials Tech.
Clinical Trials Tech
Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.
Value-Based Care & Population Health
The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest Rubix LS News
Feb 10, 2021
Rubix LS Secures $1.25 Million Seed Financing Round Culturally-Centric Life Science Company aggressively accelerates the development of the lead platform StarSense and expand the development of a Rubix LS owned clinical trial site for launching clinical trials. LAWRENCE, Mass., February 9, 2021-- Rubix LS, a minority-led life science research firm focusing on solutions to support minorities within clinical trials, announced today that it had completed a $1.25 million Seed round of financing. With the financing round being secured by many private and angel investors, the investment capitalizes on the further momentum for the virtual clinical trial platform, StarSense, and the intimate engagement with minority patients for continued care for early-stage research. Harmonizing on the events during the COVID-19 pandemic, StarSense made further advances globally to support underrepresented groups to be included in infectious disease clinical trial research programs. Furthering from inclusion, the platform has led to a 38% increase in therapeutic benefits for therapies that were otherwise unknown to support and treat specific conditions. "We're ensuring that we don't let the pandemic and any further instances of innovation disregard the underrepresented communities from accessing therapies for conditions and start building trust among the communities at large." - Reginald Swift, Founder & CEO of Rubix LS The Seed financing builds on an exceptional year for Rubix LS which saw a rapidly growing roster of clients, expansion of its internal team, and key market momentum in the white-hot areas of health inequities towards the underrepresented patient populations that has stemmed from the race for a vaccine for COVID-19. About Rubix LS Rubix LS, founded in 2016, is a culturally-centric life science research firm that is building data, products, processes, and programs to wholly support the clinical research continuum that includes minority data sets in every phase of the life science development ecosystem. Enabling its the use of virtual clinical trials, it is bridging the scientific and operational expertise to design custom made solutions that enhance minority patient attention, recruitment, engagement, support, and education so that the life science industry can make better products for everyone. Contact:
Rubix LS Frequently Asked Questions (FAQ)
When was Rubix LS founded?
Rubix LS was founded in 2016.
Where is Rubix LS's headquarters?
Rubix LS's headquarters is located at 60 Island St, Lawrence.
What is Rubix LS's latest funding round?
Rubix LS's latest funding round is Seed.
How much did Rubix LS raise?
Rubix LS raised a total of $1.25M.
Who are Rubix LS's competitors?
Competitors of Rubix LS include Syra Health, Ferrum Health, Foodsmart, HomeCare.co, Clearsense, PaySpan, Navvis, Valera Health, ArborMetrix, Upfront Healthcare and 114 more.
What products does Rubix LS offer?
Rubix LS's products include StarSense.
Compare Rubix LS to Competitors
Drugviu is a population health platform for communities of color to find relevant medication data, reviews and experiences.
MyHelse offers a customizable platform that leverages data and analytics to identify early risks at both the individual and population health levels focusing on the underserved populations.
Trella Health aims to deliver critical healthcare analytics to positively impact every care path in America, enabling agencies to thrive in the new paradigm of value-based care.
Medicom Health Interactive is a developer of online health solutions that identify at-risk consumers. The company focuses on improving the quality of care, reducing health care costs, and guiding patients through the care continuum. It is based in Minneapolis, Minnesota.
Upfront Healthcare develops a platform that automates and personalizes care navigation to engage all patients to optimize sites of care. It provides solutions like patient recall visit, medication adherence, appointment scheduling, patient referral management, and more. The company was founded in 2015 and is based in Chicago, Illinois.
Clarify Health collects records of rendered healthcare in the United States for the purpose of providing more granular and precise analytics to healthcare organizations, spanning from providers to payers and life sciences. Clarify's software solutions are fueled by a patient-level data set and incorporate clinical, claim, prescription, lab and socio-behavioral determinants of health data. Its analytics platform is powered by a technology stack inspired by those used in banking and logistics and provides doctors and insurers greater visibility into cost, quality, referrals, utilization, and member risk. The company is also helping life sciences organizations analyze and integrate rich data to determine the optimal sites and designs for clinical trials as well as accelerate clinical development timelines. The company was founded in 2015 and is based in San Francisco, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.